Literature DB >> 11287083

Origins of the many NPY-family receptors in mammals.

D Larhammar1, A Wraith, M M Berglund, S K Holmberg, I Lundell.   

Abstract

The NPY system has a multitude of effects and is particularly well known for its role in appetite regulation. We have found that the five presently known receptors in mammals arose very early in vertebrate evolution before the appearance of jawed vertebrates 400 million years ago. The genes Y(1), Y(2) and Y(5) arose by local duplications and are still present on the same chromosome in human and pig. Duplications of this chromosome led to the Y(1)-like genes Y(4) and y(6). We find evidence for two occasions where receptor subtypes probably arose before peptide genes were duplicated. These observations pertain to the discussion whether ligands or receptors tend to appear first in evolution. The roles of Y(1) and Y(5) in feeding may differ between species demonstrating the importance of performing functional studies in additional mammals to mouse and rat.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11287083     DOI: 10.1016/s0196-9781(01)00331-x

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  18 in total

1.  Novel neuropeptide Y Y2-like receptor subtype in zebrafish and frogs supports early vertebrate chromosome duplications.

Authors:  R Fredriksson; E T Larson; Y-L Yan; J-H Postlethwait; D Larhammar
Journal:  J Mol Evol       Date:  2004-01       Impact factor: 2.395

2.  C-terminal motif of human neuropeptide Y4 receptor determines internalization and arrestin recruitment.

Authors:  Lizzy Wanka; Stefanie Babilon; Kerstin Burkert; Karin Mörl; Vsevolod V Gurevich; Annette G Beck-Sickinger
Journal:  Cell Signal       Date:  2016-11-03       Impact factor: 4.315

3.  Analysis of multiple polymorphisms in the bovine neuropeptide Y5 receptor gene and structural modelling of the encoded protein.

Authors:  Tanweer Alam; Bojlul Bahar; Sinéad M Waters; Mark McGee; Torres Sweeney
Journal:  Mol Biol Rep       Date:  2011-09-23       Impact factor: 2.316

4.  Re-evaluation of receptor-ligand interactions of the human neuropeptide Y receptor Y1: a site-directed mutagenesis study.

Authors:  Paula Sjödin; Sara K S Holmberg; Helena Akerberg; Magnus M Berglund; Nina Mohell; Dan Larhammar
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

5.  Receptor subtypes Y1 and Y5 mediate neuropeptide Y induced feeding in the guinea-pig.

Authors:  Anne Lecklin; Ingrid Lundell; Leena Paananen; Jarl E S Wikberg; Pekka T Männistö; Dan Larhammar
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

6.  Neuropeptide y and neuropeptide y y5 receptor interaction restores impaired growth potential of aging bone marrow stromal cells.

Authors:  Koichi Igura; Husnain Kh Haider; Rafeeq P H Ahmed; Sulaiman Sheriff; Muhammad Ashraf
Journal:  Rejuvenation Res       Date:  2011-05-19       Impact factor: 4.663

7.  The third intracellular loop stabilizes the inactive state of the neuropeptide Y1 receptor.

Authors:  Melissa J S Chee; Karin Mörl; Diana Lindner; Nicole Merten; Gerald W Zamponi; Peter E Light; Annette G Beck-Sickinger; William F Colmers
Journal:  J Biol Chem       Date:  2008-09-23       Impact factor: 5.157

8.  Attenuated Weight Gain with the Novel Analog of Olanzapine Linked to Sarcosinyl Moiety (PGW5) Compared to Olanzapine.

Authors:  Michal Taler; Israel Vered; Rea Globus; Liat Shbiro; Abraham Weizman; Aron Weller; Irit Gil-Ad
Journal:  J Mol Neurosci       Date:  2015-11-14       Impact factor: 3.444

9.  Cloning, expression, and ligand-binding characterization of two neuropeptide Y receptor subtypes in orange-spotted grouper, Epinephelus coioides.

Authors:  Fei Wang; Weimin Chen; Haoran Lin; Wensheng Li
Journal:  Fish Physiol Biochem       Date:  2014-07-10       Impact factor: 2.794

Review 10.  Neuropeptide Y: a physiological orexigen modulated by the feedback action of ghrelin and leptin.

Authors:  Satya P Kalra; Pushpa S Kalra
Journal:  Endocrine       Date:  2003-10       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.